Miliary tb Full details for md exams 15marks

Reading Document
Medical Text Search

miliary tuberculosis pathogenesis etiology dissemination

Medical Text Search

miliary tuberculosis clinical features diagnosis investigation chest X-ray

Medical Image Search

miliary tuberculosis chest X-ray CT findings

GradeResponse
GradeResponse
GradeResponse
Medical Text Search

miliary tuberculosis treatment antitubercular therapy corticosteroids management

Medical Text Search

miliary tuberculosis complications prognosis ARDS meningitis

Here is a comprehensive, exam-ready answer on Miliary Tuberculosis suitable for a 15-mark MD question.

MILIARY TUBERCULOSIS

Definition

Miliary TB is a form of disseminated tuberculosis resulting from massive lymphohematogenous spread of Mycobacterium tuberculosis, producing uniform, discrete, 1–3 mm granulomatous lesions (resembling millet seeds) throughout one or more organs — most prominently the lungs, liver, spleen, bone marrow, meninges, and choroid.

Pathogenesis

Mechanism of Dissemination

  1. Primary infection: M. tuberculosis is inhaled as droplet nuclei → deposited in alveoli → ingested by alveolar macrophages.
  2. Containment failure: In immunocompetent hosts, a Ghon focus + caseous necrosis occurs. In susceptible individuals, the focus erodes into a blood vessel or lymphatic, releasing large numbers of bacilli.
  3. Lymphohematogenous spread: Bacilli disseminate via the bloodstream → seed multiple organs simultaneously.
  4. Granuloma formation: Each seeded focus develops into a discrete 1–3 mm granuloma ("millet seed" = milium).
  5. Two major pathways:
    • Primary miliary TB: Progressive dissemination from a fresh primary complex (children, infants)
    • Post-primary (reactivation) miliary TB: Reactivation of a latent focus → erodes into a blood vessel → systemic spread (adults, immunocompromised)

Predisposing Factors (High-risk groups)

GroupReason
HIV/AIDS (CD4 <200/μL)Loss of T-cell mediated immunity
MalnutritionImpaired macrophage function
Extremes of age (infants, elderly)Immature or waning immunity
Diabetes mellitusDefective neutrophil/macrophage function
Corticosteroid/immunosuppressive therapySuppressed CMI
Hematological malignanciesImpaired cellular immunity
Post-primary TB (reactivation)Caseous focus eroding vessel
Organ transplant recipientsIatrogenic immunosuppression
Pregnancy/postpartumRelative immunosuppression
SilicosisImpaired macrophage clearance

Pathology

  • Gross: Pinpoint yellow-white nodules (1–3 mm) scattered over organ surfaces (lung, liver, spleen, meninges)
  • Histology: Epithelioid cell granuloma with central caseous necrosis, Langhans giant cells, surrounded by lymphocytes and fibroblasts
  • Distribution in lungs: Random/hematogenous — nodules present in all zones uniformly (unlike post-primary TB which is upper-zone predominant)

Clinical Features

Presentation (Three patterns)

TypeFeatures
Acute miliary TBMost common. Acute febrile illness.
Subacute/Chronic miliary TBInsidious onset, weeks–months
Cryptic miliary TBOccult, elderly patients; no obvious pulmonary findings

Symptoms

  • Constitutional (universal): Prolonged fever (high, persistent, unremitting), night sweats, anorexia, weight loss, fatigue
  • Respiratory (50–70%): Dry cough, progressive dyspnea, tachypnea — can progress to ARDS
  • Neurological (25–40%): Headache, vomiting, altered sensorium → TB meningitis (most dangerous complication)
  • Abdominal (20–30%): Hepatomegaly, splenomegaly, abdominal pain, diarrhea
  • Ocular (rare but pathognomonic): Choroidal tubercles (seen on fundoscopy) — bilateral, pale, discrete lesions near optic disc

Signs

  • Fever (remittent/continuous)
  • Hepatosplenomegaly
  • Lymphadenopathy (peripheral)
  • Choroidal tubercles on fundoscopy (pathognomonic — found in ~13%)
  • Signs of meningism (neck rigidity, Kernig's sign) if TB meningitis present
  • Crepitations on auscultation
  • Skin: Papulonecrotic tuberculid, scrofuloderma (rarely)

Investigations

1. Chest X-Ray (Key investigation)

  • Classic pattern: Bilateral, symmetric, diffuse micronodular (1–3 mm) "snow-storm" or "millet-seed" pattern in all lung zones
  • Nodules are uniform in size and distribution
  • May be normal early in disease (first 2–3 weeks)
  • Hilar/mediastinal lymphadenopathy may coexist
Miliary TB – Chest X-ray and CT
Pre-treatment (a, b) and post-treatment at 6 months (c, d) showing classic miliary pattern with random micronodules on CXR and CT, and near-complete resolution after therapy.

2. HRCT Chest (Gold standard imaging)

  • Random micronodules (1–3 mm) with uniform distribution
  • Nodules in relation to fissures, pleura, vessels (random distribution)
  • Ground-glass opacities, interlobular septal thickening
  • More sensitive than CXR; detects early disease

3. Sputum Examination

  • AFB smear: Positive in only ~30% — often negative because lesions are hematogenous, not endobronchial
  • Culture (Löwenstein-Jensen or MGIT liquid culture): Gold standard; takes 2–8 weeks
  • Xpert MTB/RIF: Rapid molecular test, detects TB + rifampicin resistance in ~2 hours

4. Blood Investigations

  • CBC: Leukopenia or leukocytosis; pancytopenia if bone marrow involved; anemia of chronic disease
  • ESR: Markedly elevated
  • LFTs: Elevated alkaline phosphatase, bilirubin (hepatic involvement)
  • Hyponatremia: Due to SIADH (common)
  • Hypoalbuminemia
  • Serum ferritin: Markedly elevated in disseminated disease

5. Tuberculin Skin Test (Mantoux)

  • Negative in 40–70% of miliary TB cases due to anergy (T-cell exhaustion/immunosuppression)
  • A negative Mantoux does NOT exclude miliary TB

6. Interferon-Gamma Release Assays (IGRAs)

  • QuantiFERON-TB Gold / T-SPOT.TB
  • May be negative in active miliary TB due to immunosuppression
  • Useful adjunct; does not differentiate latent from active TB

7. Bronchoalveolar Lavage (BAL)

  • AFB smear + culture from BAL: Positive in 40–70%
  • Transbronchial biopsy: Granuloma on histology is highly diagnostic

8. Biopsy (Most definitive diagnostic modality)

  • Liver biopsy: Granulomas in ~80–90%; most accessible site
  • Bone marrow biopsy: Granulomas; also reveals pancytopenia cause
  • Lymph node biopsy (if lymphadenopathy present)
  • Histology: Caseating/non-caseating epithelioid granulomas with Langhans giant cells + AFB on Ziehl-Neelsen stain

9. CSF Analysis (if CNS involvement suspected — always do LP)

ParameterFinding in TB Meningitis
AppearanceClear/xanthochromic
PressureRaised
Cells100–500/μL, lymphocytic pleocytosis
ProteinRaised (>45 mg/dL)
GlucoseLow (CSF:serum ratio <0.5)
AFB smearPositive in <10%
ADAElevated

10. Fundoscopy

  • Choroidal tubercles: Bilateral, creamy-yellow, discrete lesions near optic disc — pathognomonic; seen in ~13%

Diagnosis

Miliary TB is diagnosed by a combination of:
  1. Clinical suspicion (fever + constitutional symptoms + respiratory symptoms)
  2. Classic CXR/HRCT findings (diffuse 1–3 mm nodules)
  3. Bacteriological confirmation (AFB smear/culture/Xpert from any site)
  4. Histological confirmation (caseating granuloma on biopsy)
  5. Response to anti-TB therapy (therapeutic trial in doubtful cases)
Diagnostic certainty levels:
  • Confirmed: Culture/Xpert positive or histology positive
  • Probable: Classic radiology + clinical features + positive TST/IGRA
  • Possible: Clinical + radiological features without microbiological/histological proof

Treatment

Anti-Tuberculosis Therapy (ATT)

Standard Regimen (WHO/RNTCP):

PhaseDurationDrugs
Intensive phase2 monthsHRZE (Isoniazid + Rifampicin + Pyrazinamide + Ethambutol)
Continuation phase7–10 monthsHR (Isoniazid + Rifampicin)
Total duration9–12 months (extended beyond standard 6 months due to severity)
For miliary TB with TB meningitis involvement: total duration is 12 months

Drug Doses (Adult):

DrugDose
Isoniazid (H)5 mg/kg/day (max 300 mg)
Rifampicin (R)10 mg/kg/day (max 600 mg)
Pyrazinamide (Z)25 mg/kg/day (max 2 g)
Ethambutol (E)15 mg/kg/day (max 1.6 g)
  • Add Pyridoxine (Vitamin B6) 10–25 mg/day with Isoniazid to prevent peripheral neuropathy

Corticosteroids (Adjunct Therapy)

Indications (proven to reduce mortality):
  1. TB meningitis (Grade 1 evidence) — Dexamethasone 0.4 mg/kg/day tapered over 6–8 weeks
  2. Miliary TB with ARDS — Prednisolone 1–2 mg/kg/day
  3. Pericardial TB
  4. Adrenal insufficiency (TB-related)
  • Dose: Prednisolone 1–2 mg/kg/day × 4 weeks, then taper over 4–8 weeks

HIV-Coinfected Patients

  • Start ATT immediately
  • Start ART within 2–8 weeks of ATT (earlier in severe immunosuppression, CD4 <50)
  • Use NNRTI-based ART (Efavirenz preferred); avoid Rifampicin-Protease Inhibitor combinations
  • Monitor for IRIS (Immune Reconstitution Inflammatory Syndrome)

Complications

ComplicationNotes
TB MeningitisMost serious; 20–40% mortality even with treatment
ARDSFulminant respiratory failure; high mortality
PancytopeniaBone marrow involvement
Adrenal insufficiency (Addison's)Bilateral adrenal gland TB
Hyponatremia (SIADH)Common; can cause seizures
Choroidal involvement → blindnessRare
Hepatic failureExtensive hepatic granulomas
Hemophagocytic syndromeRare; aggressive macrophage activation
Multi-organ dysfunction syndromeIn severe cases
Drug-induced hepatotoxicityCommon with HRZE; monitor LFTs

Prognosis

  • Untreated: Nearly 100% fatal
  • With treatment: Mortality ~15–20% in immunocompetent patients
  • Poor prognostic factors:
    • HIV coinfection
    • TB meningitis / ARDS
    • Delayed diagnosis
    • Drug resistance (MDR-TB)
    • Very high bacillary load
    • Extremes of age
    • Organ failure at presentation
  • Radiological resolution: Takes 3–6 months on treatment (as shown in imaging above)

Differential Diagnosis of Miliary Pattern on CXR

ConditionDistinguishing Feature
Miliary TBUniform 1–3 mm nodules; AFB culture positive
SarcoidosisUpper-lobe predominant; bilateral hilar adenopathy; non-caseating granuloma; ACE elevated
Pneumocystis pneumoniaHIV patient; bilateral ground-glass; LDH elevated
Metastatic carcinomaNodules >5 mm; varied sizes; known primary
HemosiderosisHistory of mitral stenosis/hemoptysis
HistoplasmosisEndemic area; Histoplasma serology
Langerhans cell histiocytosisYoung smokers; upper-lobe; cysts

Summary Table for Quick Revision

FeatureKey Point
Causative organismMycobacterium tuberculosis
MechanismLymphohematogenous dissemination
Pathognomonic signChoroidal tubercles (fundoscopy)
CXR findingBilateral 1–3 mm micronodules — "snow-storm"
Best imagingHRCT chest
Best diagnostic testLiver/bone marrow biopsy (caseating granuloma)
MantouxOften negative (anergy)
Treatment duration9–12 months (2HRZE + 7–10HR)
Steroid indicationTB meningitis, ARDS
Most fatal complicationTB meningitis / ARDS

References: Harrison's Principles of Internal Medicine, 21st Edition (pp. 4176, 5886); WHO Guidelines on Management of Tuberculosis (2022); Park's Textbook of Preventive and Social Medicine.
This is a shared conversation. Sign in to Orris to start your own chat.